Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial

F.R. Mauro, A.M. Carella, S. Molica, F. Paoloni, A.M. Liberati, F. Zaja, V. Belsito, A. Cortellezzi, R. Rizzi, P. Tosi, M. Spriano, A. Ferretti, M. Nanni, M. Marinelli, M.S. De Propris, S.M. Orlando, M. Vignetti, A. Cuneo, A.R. Guarini, R. Foà

Research output: Contribution to journalArticlepeer-review

Cite this